Le site du DES d'oncologie de Toulouse


High burden of subsequent malignant neoplasms and cardiovascular disease in longterm Hodgkin lymphoma survivors

Hématologie - Publié le 23/06/2019 par Gauthier Glemarec

Hodgkin lymphoma (HL) patients are at an increased risk of late adverse treatment effects. While published studies focussed on the risk of either subsequent malignant neoplasms (SMNs) or cardiovascular disease (CVD), we examined the combined burden from SMN and CVD.

Source : BJC 2018